Health CanadaGeneral Alert
Desmopressin Nasal Sprays (including Apo-Desmopressin Spray) are associated with...
Published: August 6, 2008Recall ID: 24555Category: generalCountry: Canada
Product Description & Identification
Desmopressin Nasal Sprays (including Apo-Desmopressin Spray) are associated with an increased risk of serious side effects involving water retention and decreased blood sodium levels (hyponatremia). - Notice to Hospitals
Additional Source Details
| Field | Value |
|---|---|
| N I D | 24555 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/desmopressin-nasal-sprays-including-apo-desmopressin-spray-are-associated-increased-0 |
| Title | Desmopressin Nasal Sprays (including Apo-Desmopressin Spray) are associated with an increased risk of serious side effects involving water retention and decreased blood sodium levels (hyponatremia). - Notice to Hospitals |
| Archived | 1 |
| Category | Drugs |
| Last updated | 2008-08-06 |
| Organization | Marketed health products |